Literature DB >> 14224648

FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG.

K WOROWSKI, S NIEWIAROWSKI, J PROKOPOWICZ.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; DOGS; EXPERIMENTAL LAB STUDY; FIBRINOGEN; FIBRINOLYSIS; KIDNEY DISEASES; MERCURY POISONING; PHYSIOLOGY; PLASMINOGEN; RENAL VEINS; STREPTODORNASE AND STREPTOKINASE

Mesh：

Substances：

Year:  1964        PMID： 14224648

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN： 0340-5338


× No keyword cloud information.
  5 in total

1.  [Simultaneous study of the activities of prothrombin, factor X, antihemophilic globulin, thromhin time, fibrin polymerization time and thromybocyte count in the right heart, aorta, renal vein, portal vein and inferior vena cava of the rabbit].

Authors:  K Schimpf; B Hansen; J Meier
Journal:  Klin Wochenschr       Date:  1968-03-15

2.  Fibrinolytic system in the dog with experimental renal (Goldblatt) hypertension.

Authors:  J Prokopowicz; K Worowski; A Poplawski; M Mysliwiec; S Niewiarowski
Journal:  Experientia       Date:  1967-03-15

3.  [Glomerulonephritis--nephrotic syndrome--renal vein thrombosis. Causal relationship between nephrotic syndrome and chronic renal vein thrombosis].

Authors:  W Thoenes; D Anders; D Gekle
Journal:  Klin Wochenschr       Date:  1971-12-15

4.  Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase.

Authors:  C S Kucinski; A P Fletcher; S Sherry
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

5.  Fibrinolytic components of human uterine arterial and venous blood.

Authors:  A V Mackay; P C Das; P R Myerscough; J D Cash
Journal:  J Clin Pathol       Date:  1967-05       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.